Validated and efficient methodology with experts from Latin America

Ensures no conflict of interests

Expert recommendations on diagnosis, treatment & access with knowledge of the health care systems & culture within the Region

Tool for many other related initiatives – task forces, workshops, journalist education, media training, guideline development

Manuscript developed and published quickly

Outcome/Deliverable – Published document in a scientific journal

TWO TYPES

AHF recently convened Consensus Conferences on:

CONSENSUS PAPERS

AHF convenes meetings among health experts from the Latin American Region on specific health topics to develop consensus statements, recommendations and statement papers on various health topics impacting Latin America. The papers are published in renown medical journals and are used to guide health policy and increase education in the Region to ultimately improve the health status of a particular disease.

59

Early Breast Cancer Detection and

Management in Brazil's SUS


+
58

Multiple Myeloma Treatment

in Bispecific Antibody Era


+
57

Biosimilar

Interchangeability in LATAM


+
56

Digital Pathology Challenges

and Opportunities in Latin America


+
55

PARPi treatment for

mCRPC in LATAM


+
54

AQP4-IgG testing

for NMOSD in Brazil


+
53

BRAF-mutated melanoma journey

in LATAM


+
52

Expert Opinion on

CRC in LA


+
51

Alzheimer's Disease

in Latin America and the Caribbean


+
50

Social Participation in HTA

for RD in Latin America


+
49

Policy for RD Caregivers

in Latin America


+
48

Genetic and Molecular Testing

for RDs in Latin America


+
47

BRAF testing for CRC

and Melanoma in Latin America


+
46

CKD

in Brazil


+
45

Vitiligo

in Latin America


+
44

Healthcare Disparities in Atopic

Dermatitis in Latin America


+
43

Alopecia Areata

in Latin America


+
42

Adult B-ALL

in Latin America


+
41

Newborn Screening for

RDs in Latin America


+
40

ES/WGS for diagnosing

RDs in Brazil


+
39

Molecular Testing for

Solid Tumors in Latin America


+
38

BRAF MELANOMA

in Latin America


+
37

BC/CRC Biosimilars

in Latin America


+
36

Hypofractionated Radiotherapy

for Prostate Cancer in Latin America


+
35

Roadmap to Atopic Dermatitis

in Latin America


+
34

COVID-19

in Latin America


+
33

Combination therapies for

Multiple Myeloma in Latin America


+
32

Unmet Needs of Atopic

Dermatitis in Latin America


+
31

Lupus

in Brazil


+
30

Molecular Pathology

in Brazil


+
29

NGS for oncology

in Colombia


+
28

Precision Medicine for

Breast Cancer in Latin America


+
27

CVD

in Saudi Arabia


+
26

CVD

in Latin America


+
25

KRAS Testing:

in Brazil


+
24

CDK4/6i

for Breast Cancer in Brazil


+
23

Severe Asthma

in Brazil


+
22

Osteoporosis

in Turkey


+
21

Prostate Cancer

in Brazil


+
20

Prostate Cancer

in Developing Countries


+
19

Non-Metastatic Castration Resistant

Prostate Cancer in Latin America


+
18

Hereditary Breast and

Ovarian Cancer in Brazil


+
17

Liquid Biopsy

in Brazil


+
16

Next-Generation Sequencing

in Oncology in Brazil


+
15

Osteoporosis Prevention and

Treatment in Latin America


+
14

Merkel Cell

Carcinoma in Latin America


+
13

Biomarkers and Immuno-oncologic

Therapy in Brazil


+
12

Long-Acting Reversible Contraception

in Latin America and the Caribbean


+
11

Immuno-oncology

Therapies in Brazil


+
10

Adult Vaccination

in Latin America


+
9

Targeted Oncology

Therapies in Brazil


+
8

Multiple Sclerosis in

Central America and the Caribbean


+
7

Pain Management

in Latin America


+
6

Adult Vaccination

in Latin America


+
5

Biosimilars

in Latin America


+
4

Regulation of Biosimilars

in Latin America


+
3

Meningococcal Disease

in Latin America


+
2

Elderly Influenza

in Latin America


+
1

Pertussis

In Latin America


+